Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Tonix Pharmaceuticals Holding Corp fell by 94.62m. Cash Flow from Financing totalled 36.52m or 470.10% of revenues. In addition the company used 102.00m for operations while cash used for investing totalled 29.07m.
Cash flow per share | -71.25 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.28 |
---|---|
Tangible book value per share | 4.27 |
More ▼
Balance sheet in USDView more
Current ratio | 1.15 |
---|---|
Quick ratio | 0.7181 |
Total debt/total equity | 0.2016 |
---|---|
Total debt/total capital | 0.1678 |
More ▼